Human beings with a loss function of either TREM2 or DAP12 develop an inflammatory neurodegenerative disease—Nasu-Hakola disease (NHD), leading to death in the fourth or fifth decade of life (78). Here, TYROBP is linked to Nasu-Hakola disease.